Literature DB >> 9303353

Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.

J R Westphal1, R G van't Hullenaar, J A van der Laak, I M Cornelissen, L J Schalkwijk, G N van Muijen, P Wesseling, P C de Wilde, D J Ruiter, R M de Waal.   

Abstract

We studied the relation between tumour vascular density and tumour growth rate, metastatic incidence and vascular permeability factor (VPF) mRNA levels in a human xenograft model described previously. Vascular density was determined by automated image analysis. Xenografts derived from cell lines BLM and MV3 showed the highest mean vascular density (MVD), the highest in vivo growth rate, high VPF mRNA levels and rapid development of lung metastases. Xenografts of cell lines M14, Mel57 and MV1 showed a significantly lower degree of vascularization, lower in vivo growth rates and lower levels of VPF mRNA, but formed lung metastases with a similar incidence as those of BLM and MV3. Xenografts from cell line 1F6 did not form lung metastases, whereas tumours derived from a spontaneous mutant of 1F6, designated 1F6m, gave rise to lung metastases to the same extent as Mel57, M14 and MV1 tumours. MVD values in 1F6 and 1F6m xenografts, VPF mRNA levels and in vivo growth rates of 1F6 and 1 F6m xenografts, however, were similar. In conclusion, in the melanoma xenograft model vascular density is correlated with in vivo growth rate and with in vitro VPF mRNA levels, but not with the ability to metastasize.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303353      PMCID: PMC2228011          DOI: 10.1038/bjc.1997.427

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

Review 1.  Angiogenesis.

Authors:  J Folkman; Y Shing
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  Relation of neovascularisation to metastasis of non-small-cell lung cancer.

Authors:  P Macchiarini; G Fontanini; M J Hardin; F Squartini; C A Angeletti
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

3.  Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.

Authors:  G N Van Muijen; L M Cornelissen; C F Jansen; C G Figdor; J P Johnson; E B Bröcker; D J Ruiter
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

Review 4.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 5.  Regulators of angiogenesis.

Authors:  M Klagsbrun; P A D'Amore
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

6.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

7.  Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.

Authors:  R L Barnhill; K Fandrey; M A Levy; M C Mihm; B Hyman
Journal:  Lab Invest       Date:  1992-09       Impact factor: 5.662

8.  Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice.

Authors:  M A Weterman; G M Stoopen; G N van Muijen; J Kuznicki; D J Ruiter; H P Bloemers
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

9.  Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.

Authors:  P H Quax; G N van Muijen; E J Weening-Verhoeff; L R Lund; K Danø; D J Ruiter; J H Verheijen
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

10.  The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.

Authors:  P Carnochan; J C Briggs; G Westbury; A J Davies
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more
  13 in total

1.  Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma.

Authors:  Giulio Gambarota; H W M van Laarhoven; M Philippens; W J M Peeters; P Rijken; A van der Kogel; C J A Punt; A Heerschap
Journal:  Appl Magn Reson       Date:  2010-03-28       Impact factor: 0.831

2.  Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.

Authors:  H W M van Laarhoven; G Gambarota; A Heerschap; J Lok; I Verhagen; A Corti; S Toma; C Gallo Stampino; A van der Kogel; C J A Punt
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

3.  Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.

Authors:  T G Sheidow; P L Hooper; C Crukley; J Young; J G Heathcote
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

4.  Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.

Authors:  H J Bernsen; P F Rijken; J P Peters; J H Bakker; R H Boerman; P Wesseling; A J van der Kogel
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

5.  The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.

Authors:  H J Bernsen; P F Rijken; H Peters; H Bakker; A J van der Kogel
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  The relationship between genetic aberrations as detected by comparative genomic hybridization and vascularization in glioblastoma xenografts.

Authors:  H J Gilhuis; H J Bernse; J W Jeuken; P Wesselin; S H Sprenger; H M Kerstens; J Wiegant; R H Boerman
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

7.  Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.

Authors:  Manfred Kunz; Gisela Bloss; Reinhard Gillitzer; Gerd Gross; Matthias Goebeler; Ulf R Rapp; Stephan Ludwig
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

8.  Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.

Authors:  U B Hofmann; J R Westphal; E T Waas; A J Zendman; I M Cornelissen; D J Ruiter; G N van Muijen
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

9.  Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays.

Authors:  N J W de Wit; J Rijntjes; J H S Diepstra; T H van Kuppevelt; U H Weidle; D J Ruiter; G N P van Muijen
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

10.  Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells.

Authors:  Beatrice E Bachmeier; Cristina M Iancu; Peter H Killian; Emanuel Kronski; Valentina Mirisola; Giovanna Angelini; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Mol Cancer       Date:  2009-12-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.